The role of TRIB1 in lipid metabolism; From genetics to pathways

Biochemical Society Transactions

Volumn 43, Issue , 2015, Pages 1063-1068

  Iwamoto, Sadahiko ^a   Boonvisut, Supichaya ^a   Makishima, Saho ^a   Ishizuka, Yuumi ^a   Watanabe, Kazuhisa ^a   Nakayama, Kazuhiro ^a  

^a JICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Lipid transfer protein; Molecular interaction; Single nucleotide polymorphism (SNP) association studies; Triglyceride; Very low density lipoprotein (VLDL)

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN ALPHA; LOW DENSITY LIPOPROTEIN; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR SIN3A; TRIACYLGLYCEROL; TRIBBLES HOMOLOGUE 1; UNCLASSIFIED DRUG; LIPID; PROTEIN SERINE THREONINE KINASE; SIGNAL PEPTIDE; TRIB1 PROTEIN, HUMAN;

ALLELE; ARTICLE; CHOLESTEROL BLOOD LEVEL; DYSLIPIDEMIA; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETICS; HUMAN; LIPID BLOOD LEVEL; LIPID LIVER LEVEL; LIPID METABOLISM; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REGULATORY SEQUENCE; STEATOSIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; BLOOD; METABOLISM; MOUSE; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM;

ANIMALS; HUMANS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LIPID METABOLISM; LIPIDS; MICE; MODELS, GENETIC; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; REGULATORY SEQUENCES, NUCLEIC ACID; SIGNAL TRANSDUCTION;

EID: 84947433619     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST20150094     Document Type: Article

References (36)

1. Law, M.R., Wald, N.J. and Rudnicka, A.R. (2003) Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis. BMJ 326, 1423 CrossRef PubMed
2. Lewington, S., Whitlock, G., Clarke, R., Sherliker, P., Emberson, J., Halsey, J., Qizilbash, N., Peto, R. and Collins, R. (2007) Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 370, 1829-1839 CrossRef PubMed
3. Nordestgaard, B.G., Benn, M., Schnohr, P. and Tybjaerg-Hansen, A. (2007) Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. JAMA 298, 299-308 CrossRef PubMed
4. Bansal, S., Buring, J.E., Rifai, N., Mora, S., Sacks, F.M. and Ridker, P.M. (2007) Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. JAMA 298, 309-316 CrossRef PubMed
5. Weiss, L.A., Pan, L., Abney, M. and Ober, C. (2006) The sex-specific genetic architecture of quantitative traits in humans. Nat. Genet. 38, 218-222 CrossRef PubMed
6. Schunkert, H., König, I.R., Kathiresan, S., Reilly, M.P., Assimes, T.L., Holm, H., Preuss, M., Stewart, A.F., Barbalic, M., Gieger, C. et al. (2011) Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat. Genet. 43, 333-338 CrossRef PubMed
7. Marenberg, M.E., Risch, N., Berkman, L.F., Floderus, B. and de Faire, U. (1994) Genetic susceptibility to death from coronary heart disease in a study of twins. N. Engl. J. Med. 330, 1041-1046 CrossRef PubMed
8. Hegedus, Z., Czibula, A. and Kiss-Toth, E (2007) Tribbles: a family of kinase-like proteins with potent signalling regulatory function. Cell Signal. 19, 238-250 CrossRef PubMed
9. Kathiresan, S., Melander, O., Guiducci, C., Surti, A., Burtt, N.P., Rieder, M.J., Cooper, G.M., Roos, C., Voight, B.F., Havulinna, A.S. et al. (2008) Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat. Genet. 40, 189-197 CrossRef PubMed
10. Willer, C.J., Sanna, S., Jackson, A.U., Scuteri, A., Bonnycastle, L.L., Clarke, R., Heath, S.C., Timpson, N.J., Najjar, S.S., Stringham, H.M. et al. (2008) Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat. Genet. 40, 161-169 CrossRef PubMed
11. Kathiresan, S., Willer, C.J., Peloso, G.M., Demissie, S., Musunuru, K., Schadt, E.E., Kaplan, L., Bennett, D., Li, Y., Tanaka, T. et al. (2009) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat. Genet. 41, 56-65 CrossRef PubMed
12. Nakayama, K., Bayasgalan, T., Yamanaka, K., Kumada, M., Gotoh, T., Utsumi, N., Yanagisawa, Y., Okayama, M., Kajii, E., Ishibashi, S. and Iwamoto, S. (2009) Large scale replication analysis of loci associated with lipid concentrations in a Japanese population. J. Med. Genet. 46, 370-374 CrossRef PubMed
13. Tai, E.S., Sim, X.L., Ong, T.H., Wong, T.Y., Saw, S.M., Aung, T., Kathiresan, S., Orho-Melander, M., Ordovas, J.M., Tan, J.T. and Seielstad, M. (2009) Polymorphisms at newly identified lipid-associated loci are associated with blood lipids and cardiovascular disease in an Asian Malay population. J. Lipid Res. 50, 514-520 CrossRef PubMed
14. Teslovich, T.M., Musunuru, K., Smith, A.V., Edmondson, A.C., Stylianou, I.M., Koseki, M., Pirruccello, J.P., Ripatti, S., Chasman, D.I., Willer, C.J. et al. (2010) Biological, clinical and population relevance of 95 loci for blood lipids. Nature 466, 707-713 CrossRef PubMed
15. Garcia-Rios, A., Perez-Martinez, P., Mata, P., Fuentes, F., Lopez-Miranda, J., Alonso, R., Caballero, J., Mata, N., Perez-Jimenez, F. and Ordovas, J.M. (2011) Polymorphism at the TRIB1 gene modulates plasma lipid levels: insight from the Spanish familial hypercholesterolemia cohort study. Nutr. Metab. Cardiovasc. Dis. 21, 957-963 CrossRef PubMed
16. Varbo, A., Benn, M., Tybjærg-Hansen, A., Grande, P. and Nordestgaard, B.G. (2011) TRIB1 and GCKR polymorphisms, lipid levels, and risk of ischemic heart disease in the general population. Arterioscler. Thromb. Vasc. Biol. 31, 451-457 CrossRef PubMed
17. Zhang, Z., Tao, L., Chen, Z., Zhou, D., Kan, M., Zhang, D., Li, C., He, L. and Liu, Y. (2011) Association of genetic loci with blood lipids in the Chinese population. PLoS One 6, e27305 CrossRef PubMed
18. Chambers, J.C., Zhang, W., Sehmi, J., Li, X., Wass, M.N., Van der Harst, P., Holm, H., Sanna, S., Kavousi, M., Baumeister, S.E. et al. (2011) Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet. 43, 1131-1138 CrossRef PubMed
19. Ishizuka, Y., Nakayama, K., Ogawa, A., Makishima, S., Boonvisut, S., Hirao, A., Iwasaki, Y., Yada, T., Yanagisawa, Y., Miyashita, H. et al. (2014) TRIB1 down-regulates hepatic lipogenesis and glycogenesis via multiple molecular interactions. J. Mol. Endocrinol. 24, 145-158 CrossRef
20. Kitamoto, A., Kitamoto, T., Nakamura, T., Ogawa, Y., Yoneda, M., Hyogo, H., Ochi, H., Mizusawa, S., Ueno, T., Nakao, K. et al. (2014) Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits. Endocr. J. 61, 683-689 CrossRef PubMed
21. Douvris, A., Soubeyrand, S., Naing, T., Martinuk, A., Nikpay, M., Williams, A., Buick, J., Yauk, C. and McPherson, R. (2014) Functional analysis of the TRIB1 associated locus linked to plasma triglycerides and coronary artery disease. J. Am. Heart Assoc. 3, e000884 CrossRef PubMed
22. Burkhardt, R., Toh, S.A., Lagor, W.R., Birkeland, A., Levin, M., Li, X., Robblee, M., Fedorov, V.D., Yamamoto, M., Satoh, T. et al. (2010) Trib1 is a lipid- and myocardial infarction-associated gene that regulates hepatic lipogenesis and VLDL production in mice. J. Clin. Invest. 120, 4410-4414 CrossRef PubMed
23. Ostertag, A., Jones, A., Rose, A.J., Liebert, M., Kleinsorg, S., Reimann, A., Vegiopoulos, A., Diaz, M.B., Strzoda, D., Yamamoto, M. et al. (2010) Control of adipose tissue inflammation through TRB1. Diabetes 59, 1991-2000 CrossRef PubMed
24. Satoh, T., Kidoya, H., Naito, H., Yamamoto, M., Takemura, N., Nakagawa, K., Yoshioka, Y., Morii, E., Takakura, N., Takeuchi, O. and Akira, S. (2013) Critical role of Trib1 in differentiation of tissue-resident M2-like macrophages. Nature 495, 524-528 CrossRef PubMed
25. Sung, H.Y., Francis, S.E., Crossman, D.C. and Kiss-Toth, E. (2006) Regulation of expression and signalling modulator function of mammalian tribbles is cell-type specific. Immunol. Lett. 104, 171-177 CrossRef PubMed
26. Nagiec, M.M., Skepner, A.P., Negri, J., Eichhorn, M., Kuperwasser, N., Comer, E., Muncipinto, G., Subramanian, A., Clish, C., Musunuru, K. et al. (2015) Modulators of hepatic lipoprotein metabolism identified in a search for small-molecule inducers of tribbles pseudokinase 1 expression. PLoS One 10, e0120295 CrossRef PubMed
27. Rahman, S.M., Schroeder-Gloeckler, J.M., Janssen, R.C., Jiang, H., Qadri, I., Maclean, K.N. and Friedman, J.E. (2007) CCAAT/enhancing binding protein beta deletion in mice attenuates inflammation, endoplasmic reticulum stress, and lipid accumulation in diet-induced nonalcoholic steatohepatitis. Hepatology 45, 1108-1117 CrossRef PubMed
28. Matsusue, K., Gavrilova, O., Lambert, G., Brewer, Jr, H.B., Ward, J.M., Inoue, Y., LeRoith, D. and Gonzalez, F.J. (2004) Hepatic CCAAT/enhancer binding protein alpha mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice. Mol. Endocrinol. 18, 2751-2764 CrossRef PubMed
29. Schroeder-Gloeckler, J.M., Rahman, S.M., Janssen, R.C., Qiao, L., Shao, J., Roper, M., Fischer, S.J., Lowe, E., Orlicky, D.J., McManaman, J.L. et al. (2007) CCAAT/enhancer-binding protein beta deletion reduces adiposity, hepatic steatosis, and diabetes in Lepr (db/db) mice. J. Biol. Chem. 282, 15717-15729 CrossRef PubMed
30. Lee, Y.H., Sauer, B., Johnson, P.F. and Gonzalez, F.J. (1997) Disruption of the c/ebp alpha gene in adult mouse liver. Mol. Cell. Biol. 17, 6014-6022 PubMed
31. Wang, N.D., Finegold, M.J., Bradley, A., Ou, C.N., Abdelsayed, S.V., Wilde, M.D., Taylor, L.R., Wilson, D.R. and Darlington, G.J. (1995) Impaired energy homeostasis in C/EBP alpha knockout mice. Science 269, 1108-1112 CrossRef PubMed
32. Qiao, L., MacLean, P.S., You, H., Schaack, J. and Shao, J. (2006) Knocking down liver ccaat/enhancer-binding protein alpha by adenovirus-transduced silent interfering ribonucleic acid improves hepatic gluconeogenesis and lipid homeostasis in db/db mice. Endocrinology 147, 3060-3069 CrossRef PubMed
33. Schattenberg, J.M., Singh, R., Wang, Y., Lefkowitch, J.H., Rigoli, R.M., Scherer, P.E. and Czaja, M.J. (2006) JNK1 but not JNK2 promotes the development of steatohepatitis in mice. Hepatology 43, 163-172 CrossRef PubMed
34. Uyeda, K. and Repa, J.J. (2006) Carbohydrate response element binding protein, ChREBP, a transcription factor coupling hepatic glucose utilization and lipid synthesis. Cell Metab. 4, 107-110 CrossRef PubMed
35. Dentin, R., Benhamed, F., Hainault, I., Fauveau, V., Foufelle, F., Dyck, J.R., Girard, J. and Postic, C. (2006) Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob/ob mice. Diabetes 55, 2159-2170 CrossRef PubMed
36. Speliotes, E.K., Yerges-Armstrong, L.M., Wu, J., Hernaez, R., Kim, L.J., Palmer, C.D., Gudnason, V., Eiriksdottir, G., Garcia, M.E., Launer, L.J. et al. (2011) Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet 7, e1001324 CrossRef PubMed